Visualization of in vitro protein-rejecting properties of PEGylated stealth® polycyanoacrylate nanoparticles

Biomaterials

Volumn 20, Issue 14, 1999, Pages 1269-1275

  Peracchia, M T ^a,e   Harnisch, S ^b   Pinto Alphandary, H ^a   Gulik, A ^c   Dedieu, J C ^c   Desmaele D ^d   D'Angelo, J ^d   Muller R H ^b   Couvreur, P ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CENTRE DE GÉNÉTIQUE MOLÉCULAIRE   (France)

^d CNRS   (France)

^e SANOFI   (France)

Author keywords

Nanoparticles; PEG; Polycyanoacrylate; Protein adsorption; Stealth

Indexed keywords

BLOOD; ELECTROPHORESIS; NANOSTRUCTURED MATERIALS; POLYACRYLATES; POLYETHYLENE GLYCOLS; PROTEINS; VISUALIZATION;

POLYACRYLAMIDE GEL ELECTROPHORESIS (PAGE); POLYCYANOACRYLATE; STEALTH;

BIOMATERIALS;

CYANOACRYLATE; FIBRINOGEN; NANOPARTICLE; PEGYLATED STEALTH; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; FEMALE; FREEZE FRACTURE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD PROTEINS; CYANOACRYLATES; DRUG CARRIERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FIBRINOGEN; FREEZE FRACTURING; HUMANS; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED STRAINS; POLYETHYLENE GLYCOLS;

AGOUTI PACA; ANIMALIA;

EID: 0033168385     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00021-6     Document Type: Article

References (23)

1. Gref R, Minamitake Y, Peracchia MT, Langer R. PEG-coated biodegradable nanospheres for intravenous drug administration. In: Cohen S, Bernstein H. editors. Microparticulate Systems for the Delivery of Proteins and Vaccines New York: Marcel Dekker, 1996:279-306.
2. Grislain L, Couvreur P, Lenaerts V, Roland M, Deprez-Decampeneere D, Speiser P. Pharmacokinetics and distribution of a biodegradable drug carrier. Int J Pharm 1983;15:335-45.
3. Douglas SJ, Davis SS, Illum L. Biodistribution of poly(isobutylcyanoacrylate) nanoparticles in rabbits. Int J Pharm 1986;34:145-52.
4. Frank MM, Fries LF. The role of complement in inflammatory and phagocytosis. Immunol Today 1991;12:322-6.
5. Bazile D, Prud'homme C, Bassoullet MT, Marlard M, Spenlehauer G, Veillard M. Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocyte system. J Pharm Sci 1995;84:493-8.
6. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994;263:1600-3.
7. Olivier JC, Vauthier C, Taverna M, Ferrier D, Couvreur P. Preparation and characterization of biodegradable PIBCA nanoparticles with the surface modified by the adsorption of proteins. Coll Surf B: Biointerfaces 1995;4:349-56.
8. Norman ME, Williams P, Illum L. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Biomaterials 1993;14:193-202.
9. Blunk T, Hochstrasser DF, Sanchez JC, Müller BW, Müller RH. Colloidal carriers for iv drug targeting: Plasma protein adsorption patterns on surface modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1993;14:1382-7.
10. Leroux JC, Gravel P, Balant L et al. Internalization of PLA nanoparticles by isolated human leukocytes and analysis of plasma protein adsorbed onto the particles. J Biomed Mater Res 1994;28:471-81.
11. Osterberg E, Bergström K, Holmberg K et al. Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: Comparison to PEG. J Biomed Mater Res 1995;29:741-7.
12. Yan GY, Li JT, Ang SC, Caldwell KD. Calorimetric observations of protein conformation at solid/liquid interfaces. In: Horbett TA, Brash JL, editors. Proteins at Interfaces II. ACS Symp Ser # 602, 1995:256-68.
13. Mrksich M, Sigal GB, Whitesides GM. Surface plasmon resonance permits in situ measurement of protein adsorption on self-assembled monolayers of alkanethiolates on gold. Langmuir 1995;11:4383-5.
14. Chen X, Davies MC, Roberts CJ et al. Recognition of protein adsorption onto polymer surfaces by scanning force microscopy and probe-surface adhesion measurements with protein-coated probes. Langmuir 1997;13:4106-11.
15. Peracchia MT, Vauthier C, Desmaële D et al. Biodegradable PEGylated nanoparticles from a novel MePEGcyanoacrylate-hexadecylcyanoacrylate amphiphilic copolymer. Pharm Res 1998;15:548-54.
16. Peracchia MT, Desmaële D, Couvreur P, d'Angelo J. Synthesis of a novel MePEGcyanoacrylate-hexadecylcyanoacrylate amphiphilic copolymer for nanoparticle technology. Macromolecules 1997;30:846-51.
17. Feng L, Andrade JD. Structure and adsorption properties of fibrinogen. In: Horbett TA, Brash JL, editors. Proteins at Interfaces II. ACS Symp Ser #602, 1995:66-79.
18. Peracchia MT, Fattal E, Desmaële D et al. Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting J Controlled Rel, in press.
19. Harnisch S, Müller RH. Plasma protein adsorption patterns on emulsions for the parenteral administration: Establishment of a protocol for two-dimensional polyacrylamide electrophoresis. Electrophoresis 1998;19:349-54.
20. Thode K, Ph.D. thesis, Free University of Berlin, 1996.
21. Blunk T, Ph.D. thesis, University of Kiel, 1994.
22. Bjellquist B, Pasquali C, Ravier F, Sanchez J-C, Hochstrasser D. A nonlinear wide range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. Electrophoresis 1993;14:1357-65.
23. Appel RD, Sanchez JC, Bairoch A et al. SWISS-2D PAGE: A database of two-dimensional gel electrophoresis images. Electrophoresis 1993;14:1232-8.